SAN FRANCISCO, Oct. 18 – Contending patent violations, Invitrogen filed suit against Incyte Genomics Wednesday in the US District Court of Delaware, Invitrogen told GenomeWeb .

The primary patent in contention is Invitrogen’s SuperScript form of RNAse H minus reverse transcriptase, which Invitrogen said was sold to Incyte under a research-use-only license.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.